European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline
Authors:
- Stephan C. BischoffSBStephan C. Bischoff
- Rocco BarazzoniRBRocco Barazzoni
- Luca BusettoLuca Busetto
- Marjo Campmans‐KuijpersMCMarjo Campmans‐Kuijpers
- Vincenzo CardinaleVCVincenzo Cardinale
- Ahad EshraghianAEAhad Eshraghian
- Haluk Tarik KaniHKHaluk Tarik Kani
- Wafaa KhannoussiWKWafaa Khannoussi
- Laurence LacazeLLLaurence Lacaze
- Miguel Léon‐SanzMiguel Léon‐Sanz
- Juan M. MendiveJMJuan M. Mendive
Open Access
- 12 August 2022
- journal article
- review article
- Published by Wiley in United European Gastroenterology Journal
- Vol. 10 (7) , 663-720
Abstract
Background: Patients with chronic gastrointestinal (GI) disease such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux disease (GERD), pancreatitis, and chronic liver disease (CLD) often suffer from obesity because of coincidence (IBD, IBS, celiac disease) or related pathophysiology (GERD, pancreatitis and CLD). It is unclear if such patients need a particular diagnostic and treatment that differs from the needs of lean GI patients. The present guideline addresses this question according to current knowledge and evidence.Objective: The objective of the guideline is to give advice to all professionals working in the field of gastroenterology care including physicians, surgeons, dietitians and others how to handle patients with GI disease and obesity.Methods: The present guideline was developed according to the standard operating procedure for European Society for Clinical Nutrition and Metabolism guidelines, following the Scottish Intercollegiate Guidelines Network grading system (A, B, 0, and good practice point [GPP]). The procedure included an online voting (Delphi) and a final consensus conference.Results: In 100 recommendations (3x A, 33x B, 24x 0, 40x GPP, all with a consensus grade of 90% or more) care of GI patients with obesity – including sarcopenic obesity – is addressed in a multidisciplinary way. A particular emphasis is on CLD, especially fatty liver disease, since such diseases are closely related to obesity, whereas liver cirrhosis is rather associated with sarcopenic obesity. A special chapter is dedicated to obesity care in patients undergoing bariatric surgery. The guideline focuses on adults, not on children, for whom data are scarce. Whether some of the recommendations apply to children must be left to the judgment of the experienced pediatrician.Conclusion: The present guideline offers for the first time evidence‐based advice how to care for patients with chronic GI diseases and concomitant obesity, an increasingly frequent constellation in clinical practice.Keywords
Funding Information
- United European Gastroenterology
- European Society for Clinical Nutrition and Metabolism
This publication has 430 references indexed in Scilit:
- Interdisciplinary European Guidelines on Metabolic and Bariatric SurgeryObesity Facts, 2013
- Integrating Technology Into Standard Weight Loss TreatmentJAMA Internal Medicine, 2013
- Physical activity, obesity and gastroesophageal reflux disease in the general populationWorld Journal of Gastroenterology, 2012
- Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel DiseaseScience Translational Medicine, 2011
- Obesity is an independent risk factor for clinical decompensation in patients with cirrhosisHepatology, 2011
- Fecal pancreatic elastase-1 levels in older individuals without known gastrointestinal diseases or diabetes mellitusBMC Geriatrics, 2011
- Weight-Related Effects on Disease Progression in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis TrialGastroenterology, 2009
- Osteoporosis in Inflammatory Bowel DiseaseThe American Journal of Medicine, 2009
- Obesity and Gastroesophageal Reflux: Quantifying the Association Between Body Mass Index, Esophageal Acid Exposure, and Lower Esophageal Sphincter Status in a Large Series of Patients with Reflux SymptomsJournal of Gastrointestinal Surgery, 2009
- Long-Term Follow-Up of Patients With Nonalcoholic Fatty LiverClinical Gastroenterology and Hepatology, 2009